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Most of the cancer cells require high quantity of arginine for sustaining their fast-metabolic rates. Limiting supply of 
arginine to cancer cells using arginase may prove to be of great therapeutic value. The arginase produced by a micro 
organism isolated from soil has been used in industrial production of ornithine, however its use in anticancer activities is 
scarcely studied. This study optimized soybean meal supplemented basal media for Arginase production. Arginase was 
purified using ammonium sulphate precipitation, sephadex G-100 column chromatography and DEAE chromatography 
achieving 79.2% purification fold and 24.26% yield. It had 23 KD molecular weight as determined using Native PAGE and 
was active at considerably wide pH range of 6–10 and temperature 30–50℃. Whereas the maximum arginase activity was 
noticed with Mn²+ ions followed by polyvinyl pyrrolidine (PVP) at 70 mM substrate concentration, the maximum inhibition 
of activity was caused by CuC. Streptomyces plicatus KAR 73 produced arginase on mouse mammary cell line (CID 9) was 
not inhibited by the arginase upto 6.5 U/mL. Significant (p< 0.001) inhibition in Mouse mammary tumor (C1271) cell lines 
was observed with IC50 5.2 U/mL. The ornithine has been produced earlier with Mycoplasma and Clostridium by other 
researchers but production of native arginase from Streptomyces specifically for anticancer activities has not yet been 
reported. The present study infers that Arginase produced from native Streptomyces has shown promising results thereby 
enabling feasibility assessment towards cost effective industrial production of arginase. 
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Introduction 
Cancer, with its high morbidity and mortality, 
poses serious threat to the sustenance and quality of 
life. Hence, vigorous, coordinated and evidence-based 
efforts are needed to prevent and treat carcinomas. It 
is noticeable that normal cells die during various 
developmental and stress processes. Since, apoptotic 
processes remain inactive in cancer cells, effective 
strategies are required to counter tumor propagation.
1
 
Normal adult cells synthesize adequate levels of 
arginine to maintain cellular metabolic functions.
2
 It 
becomes conditionally indispensable during tissue 
injury, metabolic disorders and disease conditions 
demanding increased supply of arginine from 
neighbouring tissues or through diet. Rapidly growing 
tumor and cancer cells require a nutrient-rich 
environment to maintain their growth. Arginine serves 
as an intermediate in the urea cycle as well as a 
precursor for protein, polyamine, creatine and nitric 
oxide. Therefore, restricting access to arginine by 
arginase may cause death of malignant cells resulting 
in defective cell cycle check-point control.
3
 Normal 
healthy cells, by contrast, become inactive and remain 
viable under arginine starvation, displaying full 
recovery upon return to arginine rich conditions.
4 
Some arginine hydrolysing enzymes including 
mycoplasma derived arginine deiminase and human 




Arginases (EC 3.5.3.1), also known as arginine 
amidinase, L-arginase, canavanase and arginine 
transamidinase, are manganese containing enzymes 
converting arginine into ornithine and urea. Apart 
from mammalian tissues, these have also been 
isolated and characterized from worms, molluscs, 
fishes, bacteria, fungi, yeast, actinomycetes, algae and 
plants. Among microorganisms actinomycetes, 
Entamoeba histolyticae, Plasmodium falciparum, 








Agaricus bisporus, Enterococcus faecalis, Evernia 
prunastri, Xanthoria parietina, Peltigera canina, 
Fasciola gigantica and Squalus acanthias
 
are reported 
to produce arginase that differ widely in their 
molecular structure.
6−7
 Use of native arginine 
deiminase (ADI) for therapeutic purposes has also 
shown antigenicity.
8
 The pegylated form of ADI has 
shown its strong anticancer activities against HCC 
and malignant melanoma.
9,10
 However, unfavorable 
effects under in vivo conditions remain to be 
thoroughly explored before clinical application of 
such conjugated enzyme system.
11
  
Precise role of arginine in cancer may include 
influence tumour initiation, promotion, progression, 




efficiency, effectiveness and applicability of native L-
arginase produced by Streptomyces plicatus KAR73 
as anti-neoplastic agent are illustrated in this paper. In 
addition, economic feasibility for production of 
microbial therapeutic enzymes may be accentuated 
using Streptomyces plicatus KAR73. Hence, the 
objective of this study included production, 
characterization and anticarcinogenic-potential 
assessment of native arginase derived from 
Streptomyces plicatus KAR73. 
 
Materials and Methods 
Chemicals and Reagents 
The chemicals and reagents were procured from 
Himedia Laboratoties Pvt Ltd, Mumbai, India; 
Thermo Fisher Scientific India Pvt Ltd, Mumbai, 
India and used as per manufacturer’s instructions. 
Streptomyces plicatus KAR73, an isolate of  
cultivated field soil of district Bhopal, Madhya 
Pradesh, India (identified using 16S RNA and 
biochemical test reported elsewhere) was maintained 
on International Streptomyces Protocol medium-2 
(ISP-2). The broad range mol wt marker of 29 KDa, 
45 KDa, 66 KDa, 97 KDa, 116 KDa and 200 KDa 
mol wt were obtained from Sigma Chemical 
Company. Mouse mammary tumor cell line C-1271 
was obtained from Cell line Repository, National 
Centre for Cell Sciences, Pune, India. The generally 
used media, buffers and reagents were obtained from 
HiMedia Pvt. Ltd. 
 
Microorganism 
The actinomycetes Streptomyces plicatus KAR73 
used in the study was islaoted from cultivated field 
soil of karond area of Bhopal, soil characteristics 
include black colour with pH 7.8, the strain was 
selected for further studies after primary screening of 





Production of Arginase 
Production of L-arginase by Streptomyces plicatus 
KAR73 was done on pre-optimised media containing 
(g/L) Glucose, 10.0; K2HPO4, 0.40; MgSO4..7H2O, 
0.05; NaCl, 0.01; FeSO4.7H2O, 0.01 supplemented 
with L-arginine 0.1 (w/v%). Inoculum density 
equivalent to 0.500 Optical density (2 × 10
6 
Colony 
forming units/mL) was added to the medium in a ratio 
of 5:95 (v/v). The variation in pH of medium and 
incubation temperature was done to assess optimum 
condition for production of arginase under shake 
conditions (150 rpm) for a period of eight days. A set 
of flasks were terminated after every 24 h and whole 
culture broth was centrifuged at 3,000 × g for 10 min 
at 4℃. Arginase activity and protein content were 
measured in supernatant, while pellet was used to 
measure growth. Growth (biomass) was quantified in 
terms of dry weight of biomass after overnight drying 
at 100℃. All the experiments were conducted in 
triple sets throughout this study. 
 
Assay for Arginase Activity and Protein Quantification 
Arginase activity was measured by the modified 
method of Roman and Ruy’s Roman.
14
 Reaction mixture 
contained 20 mM Tris HCl buffer (pH 8.0),  
2 mM MnCl2, 100 mM arginine (pH 7.5) and enzyme 
sample in total volume of 2 mL and incubated at  
37 ℃ for 1 h and stopped by adding ice cold 
trichioroacetic acid 10% (w/v) followed by 
centrifugation at 10,000 × g for 10 min at 4℃. Blank 
was processed in similar manner except that addition of 
ice cold trichioroacetic acid 10% (w/v) was done prior to 
addition of enzyme sample. Amount of L-ornithine 
present in supernatant obtained from above was 
measured using HPLC Yu.
15
 The analysis of ornithine 
level was performed after filtering the supernatant 
through 0.45 µm PVDF filter, followed by derivatizing 
with 6-aminoquioly-N-hydroxy–succinimidyl carbonate. 
The derivatives were separated with a Nova-PakTMC 18 
column. Content of Ornithine was calculated by 
referring to the standard curve. One unit of enzyme was 
defined herein as the amount of arginase that produces 1 
µmol of ornithine per minute at 37℃. The protein 
content was also determined in enzyme samples 
according to the method of Bradford Bradford
16
 using 
Bovine Serum Albumin (Himedia, India).  




Purification of Arginase 
Ammonium Sulphate Precipitation 
Purification of arginase from cell free culture broth 
was carried out in sequential ascending manner. Cell 
free culture broth was filtered twice with 0.22 µm 
millipore filters. The resultant broth was saturated 
with solid ammonium sulphate with continuous 
stirring at 4℃. Salt addition was done in an aliquot of 
1gm per 100 ml broth until complete dissolution of 
salt. The saturated solution was centrifuged at  
10000 × g for 15 min at 4℃. The pellet containing 
enzyme was dissolved in minimum amount of 10 mM  
Tris-HCL buffer (pH 7.5) containing 0.5 mM MnCl2,  
0.5 µM arginine and 5% glycerol, stored at −80℃. 
The precipitate was dialysed thrice using dialysis 
membrane overnight at 4℃ against 0.1 mM Tris-HCL 
buffer (pH 7.5).  
 
Sephadex G-100 Chromatography 
Arginase was purified using Sephadex G-100 (2 × 
50 cm) column equiliberated with 20 mM HEPES and 
0.5 mM MnCl2. Washing of column was done twice. 
Dialysed, concentrated protein mixture was applied to 
column and eluted with same buffer with a flow rate 
of 1.0 ml per minute. 
 
DEAE Cellulose Chromatography 
Active fractions obtained from above were pooled 
and applied on DEAE-cellulose column (2 × 10 cm) 
equilibrated with 10 mM Tris-HCL buffer (pH 7.5) 
containing 10% glycerol. The column was washed 
twice with buffer and enzyme elution was done using 
a linear gradient of sodium chloride (0.1–0.5 M) 
prepared in 10 mM Tris-HCL buffer (pH 7.5). The 
elute was then dialysed using dialysis membrane at 
4℃ against 0.01 mM Tris-HCL buffer (pH 7.5). The 
excess buffer from dialysate was removed by keeping 
the dialysis membrane containing sample in sucrose 
bed for 24 h at 4℃.  
 
Polyacrylamide Gel Electrophoresis 
Molecular weight was determined on 12% (w/v) 
SDS gel electrophoresis.
17
 The purified enzyme was 
treated with loading dye containing SDS 1% (w/v) 
and β-mercaptoethanol and boiled for 2–3 min at 
100℃ and loaded in wells. Sample staking was done 
at 4% gel. Resolution was carried out at 110 V. The 
mol wt was determined using broad range mol wt 
marker (Sigma Chemical Co.) of 29 KDa – 200 KDa 
mol wt. The gel was carefully removed after 
electrophoresis and stained with 0.25% (w/v) 
Coomassie brilliant blue (R-250) dissolved in 50% 
(w/v) methanol and 10% (w/v) acetic acid followed 
by destaining with 10% (w/v) acetic acid. 
Zymography of purified arginase was also performed 
with native PAGE.  
 
Characterisation of Arginase Activity 
Purified arginase was appropriately diluted before 
characterization studies. The characterization was 
performed in sequential manner and the optimum 
conditions of previous experiment were used for 
successive characterization studies. Buffers systems 
used for determining pH dependence of arginase 
activity were 0.01 M acetate buffer (pH 5), 0.01 M 
phosphate buffer (pH 6–7), 0.01 M Tris HCl buffer 
(pH 8–9) and 0.01 M borate buffer (pH 10). Effect of 
temperature on the arginase activity was studied at 
20−50℃. Effect of substrate concentration (10–100 
mM) on arginase activity was studied at optimum 
temperature and pH elucidated from above 
experiment. Activity of arginase in presence of 
inhibitors 10 mM SDS, 10 mM EDTA, 10 mM 
PMSF, 10 mM DMSO, 10 mM DTT, 20% (v/v) 
Triton X-100 and 20% (v/v) Tween-20 was carried 
out at herein identified optimum pH and temperature. 











) on enzymatic activity was also 
determined.  
 
Study of Effect of Purified Arginase on Mouse Mammary 
Tumor (C-1271) Cell Lines 
Preparation of Cell Lines for Cell Cytotoxicity Assay 
Mouse mammary tumor cell line C-1271 was 
obtained from National Centre for Cell Sciences, 
Pune, India. These were cultured in complete growth 
medium Dulbecco’s Modified Eagle’s medium 
(DMEM) containing 10% (v/v) fetal bovine serum, 
0.1m M non-essential amino acids, and 1 mM sodium 
pyruvate 100 µL/mL, penicillin 100 µL/mL, 
streptomycin 100 µl/mL and 0.2 mM L-glutamine. 
These cell lines were maintained at 37℃ in 
humidified atmosphere of 95% air and 5% CO2. Sub-
culturing was performed every 24 h with cells from 
subconfluenet cultures after treated with Trypsin-
EDTA solution (Himedia Pvt. Ltd.). After 
trypsinization, cells were counted using nebular cell 
counter and diluted appropriately. The cell viability 
was checked using trypan blue assay. The 99% viable 
cells were used for further experimentation. 
 
MTT cell Cytotoxicity Assay  
Quantitative cell cytotoxicity assay under  
different treatment conditions was determined with  












) were plated into 96 well tissue culture plates. 
The cells were allowed to reach confluence for 24 h at 
37℃. The purified arginase was added in increasing 
concentration of 0.1 to 6.5 U/mL and incubated for 
24 h. Subsequently, cytotoxicity was determined by 
MTT Assay using EZ count
TM 
MTT Cell Assay Kit. 
The optical density was measured at 570 nm  
(ELISA reader, Multiskan Ascent, Thermo Scientific, 
India). The half maximal inhibitory concentration 
(IC50 value) was defined as 50% decrease in cell 
viability.  
 
Trypan Blue Assay 
Cells with density 10
4 
cells/mL were seeded on 
plates and were allowed to multiply and adhere for 24 
h at 37℃ and 5% CO2 in a humidified atmosphere. 
Successive sequential concentration of Arginase was 
added to all the cell lines C-1271 in different Sets once 
they reached confluency. After 1 h of treatment, cells 
were trypsinized and to appropriate cell density of cell 
line (s) Trypan blue dye was mixed and incubated for 1 
min.
19
 Thereafter, 10 µl of this cell-dye suspension was 
loaded in Neubauer chamber and observed under low 
(100x) and high (400x) power of an inverted 
microscope. Number of viable (bright cells) and non-
viable cells (stained blue) were counted.  
 
Colony Forming Unit Assay Using Crystal Violet Staining 
Cell density (10
4
 cells/ml) was seeded on plates 
and allowed to adhere and multiply for 24–48 hours at 
37℃ and 5% (v/v) CO2 in a humidified atmosphere. 
The used up medium was discarded and fresh medium 
was added to each plate. Arginase enzyme was added 
as mentioned before; a set of plates untreated with 
arginase was labeled as control. On completion of 
desired incubation period plates were washed twice 
with Phosphate Buffer Saline followed by fixing with 
10% formalin for 15 minutes. Staining was done with 
Crystal Violet for 10 minutes,
20,21
 Excess stain was 
removed by washing with Phosphate Buffer Saline 
(pH 7.2). Colony forming units were counted using 
stereo and compound microscope. 
Apoptosis Assay using Annexin V- FITC and PI Assay 
The cells were cultured in tissue culture plates and 
treated with arginase, after 6 hours and 24 hours of 
incubation number of viable cells, apoptotic and 
necrotic cells were analysed.
18
 Briefly, the cells after 
treatment with purified arginase were washed with 
PBS (pH 7.2) and then trypsinized with Trypsin-
Ethylene diamine tetraacetic acid (EDTA) solution for 
1 minute. These cells were thereafter collected and 
mixed with Dulbecco’s Modified Eagle’s medium 
(DMEM) at 1600 rpm. The pellet was washed and 
stained with Annexin V-FITC antibody and PI. The 
cells were scanned for fluorescence intensity using 
Flow Cytometer (Lab Quanta). The control was also 
processed in same manner except that it was not 
treated with arginase. 
 
Statistical Analysis 
Statistical analysis was done using Epi Info
TM
 
Software available online from Division of Health 
Informatics & Surveillance (DHIS), Center for 
Surveillance, Epidemiology & Laboratory Services 
(CSELS), Centers for Disease Control and Prevention 
(CDC). The analysis was done for experimental and 
control groups. Graphical representations of the data 
were performed using GraphPad Prism. 
 
Results and Discussion 
Production Media for Arginase 
Streptomyces plicatus KAR73 was found to 
produce extra-cellular arginase with 450.5 U/mL 
activity and 3.821 mg/mL protein (Table 1). The 
production of arginase by Streptomyces plicatus 
KAR73 is found in all temperature and pH range 
tested. The overall peak effectiveness is best amongst 
three different temperature constants (28℃, 37℃ and 
42℃) at pH range of 5–10. The most suited one with 
best results is observed at pH 7.0.  
 
Optimization of Temperature and pH Tolerance Favor 
Production Potential 
Across temperature range of 28–48℃, there is 
homogeneity in peak observance for production of 
arginase to be highest at pH 7 both for individual 
Table 1 — Purification of L-arginase produced by Streptomyces plicatus KAR73 














Culture filtrate 100 ml 450.5 45050 3.821 117.90 100 — 
Precipitated by ammonium sulphate 17 ml 1974.84 33572.38 2.209 894 74.52 7.58 
DEAE-Cellulose chromatography 14 ml 2134.8 29887.2 1.15 1856.34 66.34 15.74 
Sephadex G-100 7.8 ml 4306.43 32728.86 0.832 5176 72.65 43.90 




temperature constant and variation in the temperatures 
for the same pH. This implies three fold increases in 
production of enzyme at temperature 37℃ as 
compared to temperature 28℃ (Fig. 1). Similar 
results have been observed with Alcaligenes 
faecalis.
22
 The extracellular production of arginase 
was pH dependent at 37℃ which might be due to 
alteration in permeability of membrane.  
 
Purification of Arginase 
Complete recovery of protein from culture broth of 
Streptomyces plicatus KAR73 was achieved on 65% 
(w/v) ammonium sulphate saturation. The purification 
fold increased three times (15.74 to 43.90) when the 
purification step was raised from DEAE- cellulose 
chromatography to Sephadex G-100 with respective 
yields of 66.34% and 72.65% (Table 1). It is hence 
inferred here that purification upto Sephadex G-100 
level may be commercially useful. It is noteworthy 
that the completion of designated steps of purification 
provides better results including gain in protein 
contents and purification fold as depicted by highest 
specific gravity in DEAE- cellulose chromatography.  
 
Molecular Weight of Arginase 
Studies revealed that Streptomyces plicatus KAR73 
produced only one type of arginase with its molecular 
weight being 23 KDa. While ensuring purity of 
arginase by SDS PAGE, the zymography has clearly 
indicated enzymatic action with noticeable impact. 
Purified arginase of molecular weight 75 KDa, has 
been isolated and studied from Pseudomonas 
aeruginosa IH2.
(18)
 The molecular weight (23 KDa) of 
derived arginase from Streptomyces plicatus KAR73 
in this study is comparable with that of human Arg 1 
having molecular weight in the range of 35–105 
KDa.
23,24
 Metabolic and genetic diversity of 
Streptomyces sp. is vast and require extensive studies 
to completely define them. Also, limited availability 
of the relevant published literature on Streptomyces 
plicatus produced arginase is although not self 
speaking about the similarity of size of arginase 
obtained herein with that of human arginase but the 
experimental study revealed it to be in same range. 
This range is further verified by a study from 
Warszawa, Poland observing human heart arginase to 
be 30 KDa
25
 and Arginase II from Heteropneustes 
fossilis showing 96 KDa band on native PAGE in 




Characterization of Arginase Activity 
The arginase was found to be active in broad range 
of pH from 6 to 10 with optimum activity at pH 7.0–
8.0 (Relative activity 99.14%–100%) (Fig. 2a). The 
range of pH 6.0 to pH 10.0 observed in our study on 
activity of purified arginase produced is in resonance 
with the cellular environmental pH and hence 
anticarcinoma potential has wide ranging applicability 
in on site anticarcinoma action. The maximum 
activity of arginase produced by Streptomyces 
plicatus KAR 73 as pH (7.5 pH) in this study is in 
near absolute resonance with human physiological pH 
(7.2–7.4 pH), whereas other studies show maximal 
activity in outlier pH viz., Bacillus anthracis arginase 
activity occurred with nickel at an alkaline pH 9.0 in a 
study from University of South Alabama, USA.
27
 
Also, it is well known fact that cancerous cell have 
slightly acidic pH and thus the arginase obtained from 
Streptomyces plicatus KAR 73 may prove to be more 
suitable for cancer treatment as compared to those 
obtained from Buffalo liver which was optimally 
active at pH 9.2.
(28)
 Wheatley and his co-workers
5
 
have reported that bovine liver arginase is remarkably 
heat resistant enzyme with a long life on storage at 
4℃ in lyophilized form and is active at pH 7.2 than at 
pH 9.9 while arginase derived herein was maximally 
active at pH 7.5.  
Arginase from Streptomyces plicatus KAR 73 was 
active and stable at 25−42℃ with 100% relative 
activity at 37℃ (Fig. 2b). It is noteworthy that 
relative activity of arginase was almost stable in the 
temperature range 30–37℃ with progressive 
difference of 0.002%. Cai and coworkers
8 
have 
reported production of thermostable arginine 
deiminase by Enterococcus faecalis SK23.001. 
Thermostable arginase from Geobacillus 
thermodentrificans NG80-2 was found to be 
optimally active at pH 9 and temperature of 80℃.
21
 In 
the present study, the purified arginase from 
 
 
Fig, 1 — Effect of pH and temperature on production of Arginase 
by Streptomyces plicatus KAR-73 grown on medium containing 
glucose and arginine as carbon and nitrogen source under shake 
conditions (150 rpm) 




Streptomyces plicatus KAR 73 is found active in a 
broad range of temperature and tolerated even 50℃. 
The purified arginase was found to be active at 
temperature range of 30–40℃ thereby making it 
suitable for therapeutic purposes under physiological 
conditions. Recently, purification of arginase from 
Camel liver done using heat denaturation, ammonium 
sulphate precipitation, DEAE-cellulose, SP-Sepharose 
and Sephadex G 100–120 chromatography columns 
has shown its optimum temperature activity at 70℃.
29
 
The maximum arginase activity was noticed at  
70 mM Arginine concentration (Fig. 2c).  
All the inhibitors and detergents used in the study 
caused reduction in enzyme activity, EDTA caused 
59.7% inhibition and PMSF caused 21.8% inhibition, 
respectively. Arginase activity was found to be even 
higher than that of control in presence of Mn²
+
, while 
only 15.7% residual activity was observed with Cu
2+ 
metal ion as compared to control (Fig. 2d). Arginase 
activity inhibition was noted with other metal ions as 
well. Interestingly, presence of PVP did not influence 
arginase activity under in vitro conditions. The 
observed inhibition of arginase by CuC, FC and CaC 
may assist in the controlled production, activity and 
interaction of arginase with concurrent use of drugs, 
chemicals and other therapeutic interventions. In this 
study, enhancement in the activity of arginase was 
observed in presence of Mn
2+
 and PVP. It is 
noticeable that Arginases Arg I and Arg II from 
Fasciola gigantica have also been observed activated 
by Mn
2+ 















 Similarly, recombinant 
Plasmodium falciparum arginase activity has been 
found to be dependent on Manganese.
31
 D-arginase 
from Arthrobacter sp KUJ8602 revealed an optimum 
pH of 9.5 and requirement of Zn
2+
 for activation 
instead of manganese ions.
31
 Activity of 
Saccharomyces cerevisiae arginase was found to be 
dependent on Mn
2+ 
ions, and removal of ions via 




Lytic Potential Confirmed by Early Apoptosis, Late Apoptosis 
and Dead Cells 
The Mouse mammary tumor cell line (C1271) was 
found to be inhibited by different concentrations of 
arginase (0.1 to 6.5 U/mL) with IC50 5.2 U/mL  
(Fig. 3). Dead cells were confirmed post staining and 
treatment with purified arginase under visualization 
through Trypan Blue staining of C1271. The 
disseminated fragmentation of CFU assay, as 
 
Fig. 2(a–d) — (a) Relative activity of purified arginase produced by Streptomyces plicatus KAR 73 at different pH under in vitro 
conditions; Assay conditions temperature 30℃ and buffers (pH 5–10), (b) Relative activity of purified arginase produced by 
Streptomyces plicatus KAR 73 at different temperature under in vitro conditions; Assay conditions pH 7.5 and temperature (25℃–42℃). 
*Copper chloride (CuC), PVP, EDTA, magnesium chloride (MgC), PMSF, ferric chloride (FC), calcium chloride (CaC) and manganese 
chloride (MnC), (c) Effect of substrate concentration on arginase activity; The arginase activity is expressed as relative activity the assay 
conditions were pH 7.5 and 37℃ temperature and (d) Effect of activators and inhibitors on arginase activity; The results are expressed in 
terms of residual activity remaining after treatment with activators and inhibitors under in vitro conditions; Assay conditions pH 7.5 and 
temperature (37℃) 




observed through crystal violet staining of arginase 
treated plate in comparison to same staining for 
control plate illustrates the non-viability of cells 
including clumps of dead cells (Fig. 4). The 
confirmation was met by Annexin V FITC staining 
showing live apoptotic and dead cells through 
morphological visualization. The observance of 
90.44%, 3.63%, 5.26% and 0.68% being apoptotic, 
early apoptotic, dead cells, and viable cells 
respectively, underlines that there is high lytic 
potential of arginase for carcinoma cells (Fig. 5).  
Arginine deiminase (ADI) has been reported to 
exert inhibitory effects on cancer cells under in vitro 
and in vivo conditions as depicted in earlier studies for 
Pegylated enzymes.
11
 It is further approved by the 
present study even for native enzyme(s). The result of 
cell cytotoxicity assay (Fig. 5) illustrates the 
acceptability of arginase for use in the human tissues 
with unhindered and un-interfered biological activity 
required for normal cell functioning and maintenance 
of homeostasis of body systems.  
It is evidenced by apoptosis and cell death even in 
the presence of Arginosuccinate synthetase enzyme in 
this study, whereas it was hypothesized till now that 
its absence is essential for any effective 
internvention.
12,23,24
 Resonance of observations of this 
study with natural occurrences in cancer cell growth 
and development is found unique for cellular milieu. 
It therefore makes the arginase borne of Streptomyces 
plicatus most suited for effective interventions 
throughout the spectrum of cancers and their stages. 
However, the ADI has two major disadvantages. 
Firstly, ADI is not produced by mammals and must be 
derived from microbes. As a consequence, nascent 
ADI is strongly antigenic in mammals.
33
 Secondly, 
ADI has a short circulating half-life in mammals 
(approx. 5 h) and is to be essentially administered in 
large daily dose to inhibit tumors. The ADI has also 
been formulated with polyethylene glycol to produce 
ADI-SS PEG 20,000 MW, which is found safe and 
non toxic in mice.
11
 It has also been stated to be 
arginine specific and has no role for other 
 
 
Fig. 3 — IC50 of Arginase against C1271 cell lines determined 




Fig. 4 — Colony forming unit assay: C1271 cell line were 
cultured in complete growth medium DMEM with 5% FBS, 24 h 
incubation period (a) Microscopic observation of control plate 
(first quadrant) after Crystal violet staining; (b) Microscopic 




Fig. 5 — Dose and time dependent cycle of early apoptosis- apoptosis- death among C1721 mammary carcinoma cells using purified 
arginase derived from S. plicatus KAR 73; Flow cytometric analysis was conducted using Annexin V-FITC/PI for (a) After 1 h showing 
number of viable cell, early apoptotic and apoptotic cells (b) After 24 h showing quantum of early apoptotic, apoptotic and dead cell 






thereby proving anticancer 
activity of arginase derived from S. plicatus KAR 73 
in this study. 
 
Conclusions 
The arginase derived from Streptomyces plicatus 
KAR 73, as illustrated vide this study, is facilitatory 
to anticancer research and its industrial applications. 
The arginase produced herein is within the size range 
of human arginase thus assuring it to be bioacceptable 
with special reference to antigenicity. Another 
highlight of this study is physiologically ambient 
similarity of Streptomyces sp. borne arginase with 
human arginase as urea and ornithine are byproduct of 
both these unlike commercially available pegylated 
arginine deiminase having outcome as citrulline and 
ammonia. It is hence concluded that in vitro effect of 
arginine deprivation on adenocarcinoma cell lines 
through native arginase is a promising way forward to 
the carcinoma therapy. The ray of hope for the public 
health based utility of arginase in cancer treatment is 
indeed bright since autophagy targeting drugs in 
combination with standard chemotherapies will add to 
the multipronged approach for cancer therapy. 
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